edited by Marco Chinol
Radionuclide Peptide Cancer Therapy offers illustrative coverage of this new method to treat tumors associated with brain, breast, lung, and neuroendocrine cancers.
Features:
- Covers practical aspects of this new anti-cancer therapy
- Provides a comprehensive set of chapters by experts in the field, providing basic background, the latest clinical applications, dosimetric aspects, and regulatory requirements
- Reviews the technology of peptide production, aspects of radiolabeling, and the results of their clinical applications obtained at acknowledged institutions
- Includes two sections that present novel strategies to enhance the spectrum of peptide application
Contents
Theory and Production of Peptides for Radionuclide Therapy
- Peptide Structure and Analysis
- Molecular Pharmacology of Receptors
- Receptors Distribution and Biochemical Characterization
Radiolabeling Mechanisms and Strategies
- Developments of Radiolabeled Peptides
- Receptor Targeting for Tumor Therapy with Radiopeptides
- New Radionuclides for Peptide Therapy
- Pre-Clinical Comparison of Radiolabeled Peptides for Radionuclide Therapy
Clinical Therapeutic Applications
- Phase I Therapeutic Studies
- Response to Treatment with Radiolabeled Peptides
- Receptor Radionuclide Therapy: From 90Y to 177Lu Labeled Peptides
- Therapeutic Potential of Radiolabeled Peptides with Beta and Alpha Emitters
- Receptor-Mediated Radionuclide Therapy: The European Institute of Oncology Experience
Dosimetric Aspects and Regulatory Requirements
- Radiation Dosimetry in Preparation to Therapy
- Dosimetry and Critical Organs
- Regulatory Requirements for Therapy Trials
Future Perspectives
- Advances in the Field of Radiopeptides for Therapy
Index